| Literature DB >> 32614740 |
Rajesh Kumar1, Seetha Harilal1, Abdullah G Al-Sehemi2, Githa Elizabeth Mathew3, Simone Carradori4, Bijo Mathew5.
Abstract
COVID-19, a type of infection that emerged in Wuhan, has become a pandemic affecting people worldwide and is rapidly spreading and evolving. Day by day, the confirmed cases and deaths are increasing many folds. SARS-CoV-2 is a novel virus; therefore, limited data are available to curb the disease. Epidemiological approaches, such as isolation, quarantine, social distancing, lockdown, and curfew, are being employed to halt the spread of the disease. Individual and joint efforts all over the world are producing a wealth of data and information which are expected to produce therapeutic strategies against COVID-19. Current research focuses on the utilization of antiviral drugs, repurposing strategies, vaccine development, as well as basic to advanced research about the organism and the infection. The review focuses on its life cycle, targets, and possible therapeutic strategies, which can lead to further research and development of COVID-19 therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: ACE2; Antiviral drugs; COVID-19; Drug repurposing; MERS-CoV; SARS-CoV; SARS-CoV-2; Vaccines; coronavirus
Year: 2021 PMID: 32614740 DOI: 10.2174/0929867327666200702151018
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530